NPI: 1528319621 · BRISTOL, PA 19007 · General Acute Care Hospital · NPI assigned 09/28/2012
Authorized official DOAN, CHRISTOPHER controls 20+ related entities in our dataset. Read more
| Authorized Official | DOAN, CHRISTOPHER (MANAGING ASSOCIATE GENERAL COUNSEL) |
| NPI Enumeration Date | 09/28/2012 |
Other providers sharing the same authorized official: DOAN, CHRISTOPHER
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 27 | $4K |
| 2019 | 298 | $20K |
| 2020 | 7,403 | $709K |
| 2021 | 22,780 | $2.37M |
| 2022 | 12,188 | $1.90M |
| 2023 | 14,687 | $2.09M |
| 2024 | 16,815 | $1.62M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 12,097 | 11,511 | $2.84M |
| G0378 | Hospital observation service, per hour | 1,715 | 1,453 | $2.38M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 8,279 | 7,846 | $1.75M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4,877 | 4,654 | $803K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2,925 | 2,712 | $384K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,581 | 1,309 | $214K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 512 | 495 | $110K |
| 96361 | Intravenous infusion, hydration; each additional hour | 874 | 811 | $98K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 701 | 199 | $12K |
| 96375 | Therapeutic injection; each additional sequential IV push | 675 | 599 | $10K |
| 80053 | Comprehensive metabolic panel | 4,117 | 3,482 | $10K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 806 | 215 | $9K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 31 | 31 | $7K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 449 | 399 | $6K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 79 | 79 | $6K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 655 | 600 | $6K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 42 | 41 | $5K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 69 | 66 | $5K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4,253 | 3,674 | $5K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 104 | 99 | $5K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1,998 | 1,766 | $4K |
| 70450 | Computed tomography, head or brain; without contrast material | 254 | 235 | $3K |
| 10060 | 12 | 12 | $3K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 29 | 26 | $2K |
| 71046 | Radiologic examination, chest; 2 views | 247 | 238 | $2K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,294 | 1,045 | $2K |
| 71045 | Radiologic examination, chest; single view | 794 | 729 | $2K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 327 | 317 | $2K |
| OP250 | 292 | 226 | $1K | |
| 84484 | 689 | 576 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 757 | 698 | $1K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 54 | 54 | $1K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 25 | 25 | $962.76 |
| 83690 | 1,028 | 957 | $920.46 | |
| 36415 | Collection of venous blood by venipuncture | 4,933 | 4,132 | $878.07 |
| 80320 | 396 | 358 | $797.72 | |
| 73630 | 140 | 122 | $770.09 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 14 | 14 | $646.40 |
| 87086 | Culture, bacterial; quantitative colony count, urine | 503 | 465 | $635.32 |
| 85027 | 476 | 425 | $618.58 | |
| 81025 | 861 | 820 | $603.45 | |
| 81003 | 1,053 | 983 | $491.59 | |
| 72110 | 26 | 26 | $480.27 | |
| 85730 | 425 | 380 | $460.20 | |
| 80329 | 329 | 221 | $458.11 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 246 | 124 | $423.72 |
| 81001 | 727 | 673 | $376.12 | |
| 72125 | Computed tomography, cervical spine; without contrast material | 30 | 26 | $356.20 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 243 | 205 | $336.38 |
| 85610 | 460 | 407 | $318.64 | |
| 83880 | 77 | 68 | $303.52 | |
| 84443 | Thyroid stimulating hormone (TSH) | 88 | 81 | $258.33 |
| 85007 | 255 | 235 | $210.79 | |
| 73610 | 14 | 12 | $204.78 | |
| 83735 | 396 | 214 | $196.53 | |
| J7030 | Infusion, normal saline solution , 1000 cc | 2,507 | 2,097 | $174.14 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,741 | 1,403 | $165.18 |
| 87040 | 36 | 26 | $140.00 | |
| 83605 | 52 | 48 | $104.00 | |
| 85379 | 44 | 39 | $95.40 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1,103 | 972 | $92.97 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 194 | 160 | $87.50 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 593 | 503 | $79.24 |
| 82550 | 98 | 86 | $71.90 | |
| 99406 | 20 | 19 | $71.65 | |
| J3490 | Unclassified drugs | 1,408 | 793 | $58.52 |
| 82962 | 221 | 150 | $57.20 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 185 | 137 | $39.36 |
| 80061 | Lipid panel | 59 | 50 | $30.68 |
| 84100 | 245 | 119 | $26.20 | |
| 87186 | 12 | 12 | $24.00 | |
| 84703 | 14 | 13 | $21.76 | |
| 87077 | 12 | 12 | $21.30 | |
| 86900 | 29 | 24 | $17.23 | |
| 82947 | 51 | 42 | $9.90 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 46 | 37 | $7.83 |
| 83036 | Hemoglobin; glycosylated (A1C) | 26 | 24 | $7.00 |
| 80076 | 30 | 29 | $6.54 | |
| J2060 | Injection, lorazepam, 2 mg | 153 | 128 | $5.11 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 338 | 301 | $3.78 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 337 | 298 | $1.76 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 22 | 12 | $0.24 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 113 | 99 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 32 | 26 | $0.00 |
| OP257 | 52 | 25 | $0.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 23 | 17 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 15 | 12 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 25 | 25 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 29 | 28 | $0.00 |